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INTRODUCTION 
 
Traumatic optic neuropathy is a devastating potential 
complication of  closed head injury. The hallmark of an optic 
neuropathy, traumatic loss of visual function, which can manifest by 
subnormal visual acuity, visual field loss, or colour vision dysfunction. 
The presence of an afferent pupillary defect strongly suggests a 
prechiasmal location for the injury and is necessary to validate the 
diagnosis of traumatic optic neuropathy. Vision loss associated with 
traumatic optic neuropathy can be partial or complete and temporary or 
permanent. 
Approximately 1.5% to 5% of patients with closed head injuries 
have damage to visual pathways (4-6 / 100,000 general population / yr). 
These injuries can be divided into anterior and posterior lesions. 
Anterior lesions shows ophthalmoscopic abnormalities (eg. Central 
retinal artery occlusion) and usually associated with a variety of easily 
recognized injuries to the globe. Anterior lesions may include optic 
nerve avulsion, traumatic anterior ischemic optic neuropathy, anterior 
optic nerve sheath hematoma. Posterior lesions are free of 
ophthalmoscopic findings, but disc edema and disc pallor do occur. 
Posterior traumatic optic neuropathy is characterised by visual loss that 
occur in the presence of an afferent pupillary defect but without 
evidence of injury to the eye or optic nerve.  
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HISTORY 
 
Hippocrates noted the association of trauma just above the 
eyebrow and  gradual vision loss. By the 18th century, the relationship 
between frontal trauma and vision loss with an absence of ocular injury 
was well appreciated. In 1879, Berlin described the first pathologic 
examination of the optic nerve after head trauma. In 1890, Battle first 
distinguished penetrating direct from nonpenetrating indirect optic nerve 
injuries. The 20th century saw significant progress in defining the 
classification, pathophysiology, and management of traumatic optic 
nerve injuries.  
Historically, observation, medical corticosteroid therapy, or optic 
canal decompression has been advocated for the treatment of traumatic 
optic neuropathy. In the early 1900s, transcranial unroofing of the optic 
canal was the surgical procedure of choice for traumatic optic 
neuropathy treatment. This  procedure was used sparingly because of the 
inherent risks of intracranial  surgery. In the 1920s, Sewell performed a 
transethmoidal optic canal decompression by removing the lamina 
papyracea and medial wall of the optic  canal. Although his technique 
was refined by progressive advances in transnasal, transantral, 
transorbital, and external paranasal sinus surgery, the technique was not 
performed routinely until the 1960s in Japan and the 1980s in the United 
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States. During this period, systemic corticosteroid treatment was also 
extended to treat traumatic optic neuropathy.           
Recent advances in endoscopic instrumentation and intranasal 
sinus surgical techniques have refined extracranial surgical approaches 
for TON. Currently, endoscopic optic nerve decompression (EOND) via 
an intranasal and transethmoidal or transsphenoidal approach has gained 
popular support. 
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ANATOMY OF THE OPTIC NERVE  
WITH BLOOD SUPPLY 
EMBRYOLOGY 
a) Optic nerve fibres develop from the nerve fibre layer of the 
retina which grow into the optic stalk by passing through the 
choroidal fissure and pass posteriorly to the brain. 
b) Glial system of the nerve develops from the neuroectodermal 
cells forming the outer wall of optic stalk. 
c) The glial septa surrounding the nerve bundles are composed of 
astroglia that differentiate from the cells of the inner wall of the 
optic stalk. 
d) Sheaths of the optic nerve are formed from the layer of 
mesenchyme which surrounds the optic stalk [like meninges of 
other parts of central nervous system], between the 3rd and 7th 
month of gestation. 
e) Myelination of nerve fibres begins from the chiasma at about 7th 
month, proceeds distally and reaches the lamina cribrosa just 
before birth and stops 
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ANATOMY OF OPTIC NERVE 
Each optic nerve starts from optic disc and extends up to optic 
chiasma, where the two nerves meet. It consists of axons originating 
from ganglion cells. It also contains the afferent fibres of light reflex. 
PARTS OF OPTIC NERVE 
The optic nerve is about 47-50mm in length and can be divided 
into four parts: 
a) Intraocular(1mm) 
b) Intraorbital (30mm) 
c) Intracanalicular (6-9mm) 
d) Intracranial (10mm) 
INTRAOCULAR PART 
This part passes through the sclera, choroid and finally appears in 
the eye as optic disc. The intraocular portion of optic nerve head has an 
average diameter of 1.5mm, which expands to approximately 3mm just 
behind the sclera, where the neurons acquire a myelin sheath. 
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The optic nerve head divided into four parts 
1. Surface nerve fibre layer 
This part is essentially composed of axonal bundles, i.e. nerve 
fibres of retina (94%) which converge on optic disc and astrocytes 
(5%). 
2.  Prelaminar region 
The predominant structures at this level are neurons and a 
significantly increased quantity of astroglial tissue. 
3.  Lamina cribrosa region 
It is a fibrillar sieve-like structure made up of fenestrated sheets of 
scleral connective tissue lined by glial tissue. It bridges the scleral 
canal. The bundles of optic nerve fibres leave the eye through 
these fenestrations. The lamina cribrosa gets its rich blood supply 
from the circle of Zinn. 
4.  Retrolaminar region 
         This area is characterised by a decrease in astrocytes and the 
acquisition of myelin that is supplied by oligodentrocytes. The 
addition of myelin sheath nearly doubles the diameter of optic 
nerve (from 1.5 to 3.0mm) as it passes through the sclera. The 
axonal bundles are surrounded by connective tissue septa. 
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INTRAORBITAL PART 
This part of optic nerve extends from back of eyeball to optic 
foramina. This part is slightly sinuous to give play for the eye 
movements. The relations are as follows: 
• The optic nerve in the orbit is covered by dura, arachnoid and pia. 
The pial sheath sends septa to divide the nerve into fasciculi. The 
subarachnoid space containing Cerebrospinal fluid ends blindly at 
the sclera but continues intracranially. 
• Central retinal artery and vein crosses the Subarachnoid space to 
enter the nerve on its inferomedial aspect about 10mm from the 
eyeball. 
• Posteriorly, near the optic foramina, the optic nerve is closely 
surrounded by the annulus of Zinn and the origin of four recti. 
Some fibres of superior rectus and medial rectus muscles are 
adherent to its sheath here. 
• Anteriorly, the nerve is separated from the extra ocular muscles 
 by the orbital fat. 
• The long and short ciliary nerves and arteries surround the optic 
nerve before these enter the eyeball. 
• Between the nerve and the lateral rectus are situated the ciliary 
ganglion, divisions of oculomotor nerve, the nasociliary nerve, the 
sympathetic and the abducent nerve.  
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• The ophthalmic artery, superior ophthalmic vein and the 
nasociliary nerve cross the optic nerve superiorly from lateral to 
medial side. 
INTRACANALICULAR PART 
• This part is closely related to the ophthalmic artery which crosses 
the nerve inferiorly from medial to lateral side within the dural 
sheath. 
• Sphenoid and posterior ethmoidal sinuses lie medial to it and are 
separated by a thin bony lamina. 
INTRACRANIAL PART 
• This part, about 10 mm in length lies above the cavernous sinus 
and converges with its fellow (over the diaphragma sellae) to 
form the chiasma. 
• It is ensheathed in pia matter, but receives arachnoid and dural 
sheaths at its entry into the optic canal. 
• The ophthalmic artery arises from the ICA (Internal carotid 
artery) below the optic nerve at about its middle. 
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MENINGEAL SHEATHS OF OPTIC NERVE 
• The intracranial part of optic nerve is covered by pia only, while 
the intracanalicular part and intraorbital parts have three 
coverings: the pia, arachnoid and dura. 
• The meningeal sheaths and subarachnoid and subdural spaces 
around the optic nerve are continuous with those of the brain. 
• Anteriorly, all the three meningeal sheaths terminate by becoming 
continuous with the sclera. 
• At the apex of the orbit, the dura split into layers, the outer is 
continuous with the periosteum of the orbit while the inner forms 
the dural sheath of the optic nerve. 
• The pia sends numerous septa to the optic nerve, dividing its 
fibres into fascicles.    
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BLOOD SUPPLY OF THE OPTIC NERVE 
ARTERIAL SUPPLY 
1. Intra ocular part 
a. Surface nerve fibre layer:  this part is supplied by capillaries 
from retinal arterioles, which anastomose with vessels of the 
prelaminar region. 
b. Prelaminar region: this part is supplied by vessels from 
peripapillary choroidal system or from separate branches of the 
short posterior ciliary arteries. 
c. Lamina cribrosa region: this part is supplied by ciliary vessels 
from the short posterior ciliary arteries and arterial circle of Zinn-
Haller.                         
d. Retrolaminar region is supplied by both ciliary and retinal 
circulation, the former coming from recurrent pial vessels and the 
later from pial plexus of  CRA (central retinal artery).   
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2. INTRAORBITAL PART 
a) Periaxial system of vessels derived from the six branches of ICA 
namely: ophthalmic A, long posterior ciliary arteries , short 
posterior ciliary arteries, lacrimal A and central retinal A before it 
enters the optic nerve and circle of Zinn. 
b) Axial system of vessels derived from 1.the intraneural branches 
of the CRA, 2.central collateral arteries which come off from the 
CRA before it pierces the nerve and 3.central artery of optic 
nerve.  
The two systems have anastomosis between them. 
3. INTRACANALICULAR PART  
The nerve within the optic canal is supplied only by the periaxial 
system of vessels and is fed mainly by the ophthalmic A. 
4. INTRACRANIAL PART 
This part of the optic nerve is exclusively supplied by the 
periaxial system of vessels. The plexus here is contributed by 4 sources: 
a) branches from ICA either directly or through the recurrent branch of 
anterior superior hypophysial A, b) branches from anterior cerebral 
artery c) small recurrent branches from the ophthalmic A and d) the 
twigs from the anterior communicating A.  
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VENOUS SUPPLY                                                                                                             
• The venous return from the optic nerve head (ONH) is by the 
Central retinal vein (CRV). 
• The orbital part is drained by peripheral pial plexus and also by 
CRV in the distal part. 
The intracranial part is drained by the pial plexus which ends in 
anterior cerebral vein and basal vein. 
OPTIC CANAL 
The optic nerve is transmitted to the brain through the optic canal, 
a foramen of lesser wing of sphenoid. The orbital opening is elliptical 
with the major axis vertical and minor axis horizontal. The intracranial 
opening is also elliptical with a 90° rotation in the orientation of axis, so 
that the horizontal axis is the major axis and the vertical axis is the 
minor axis. The optic canal is 9.22 mm in length on average. The medial 
wall of the optic canal is the thinnest. This bone separates the ethmoidal 
air cells and sphenoid sinus.           
The canal transmits the optic nerve with its dural sheath, the 
ophthalmic artery and the fibres of sympathetic carotid plexus. Unlike 
any other portion of optic nerve, the intracanalicular part is tightly 
bound. Within the canal the optic nerve dura fuses with the periosteum 
of the optic canal. 
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ETIOLOGY 
Traumatic optic neuropathy (TON) is most commonly caused by 
motor vehicle and bicycle accidents (15-75% of cases, depending on 
the series). Falls (15-50% of cases) are the next most common cause, 
followed by physical violence and recreational sports. 
Direct traumatic optic neuropathy is the term used when the 
optic nerve is impinged, crushed, or transected. These injuries are 
usually the result of open craniofacial trauma, such as penetrating 
wounds (eg, from knives) or extensive crush injury with displaced 
cranio-orbital fractures. 
Indirect traumatic optic neuropathy occurs in the absence of 
direct optic nerve injury and is more common than direct traumatic optic 
neuropathy. 
Blunt trauma classically occurs following rapid decelation injuries 
to the anterofrontal regions of the head. Trauma to the outer third of the 
superior orbital rim is transmitted directly to the optic canal where the 
optic nerve is tethered at both ends by the dura.  
Severity of the trauma does not always correlate with the degree 
of visual loss. The incidences such as minor fall after tripping or hitting 
the side of the head against a solid object resulting in a frontal blow are 
adequate to produce a posterior traumatic optic neuropathy. 
  14
The presence or severity of orbital fractures neither directly 
predicts the severity of visual loss nor determines prognosis.TON may 
be associated with the fracture of the medial wall, optic canal, zygoma 
or floor. Patients with optic canal fracture may regain normal vision 
without intervention and those with no fracture may present with no 
light perception vision that persists despite all interventions. 
TON is most often seen in boys in their first or second decade of 
life. Patients older than 40 yrs of age were found to have worst visual 
outcome independent of mechanism of injury, severity of visual loss, or 
intervention utilized.    
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CLASSIFICATION OF OPTIC NERVE INJURURIES 
Anatomical classification 
Anatomically it can be classified as, 
1.  Optic disc trauma (avulsion) 
2.  Anterior optic neuropathy 
3.  Posterior optic neuropathy. 
Optic disc trauma 
Avulsion of the optic nerve as it enters the globe produce a partial 
ring of haemorrhage at the optic nerve head. Avulsion site may be 
visible as a crescentic dark area at the disc. 
Anterior optic neuropathy 
Injury to the proximal portion of the optic nerve within 10 mm of 
the globe, anterior to where the central retinal artery enters and the 
central retinal vein leaves nerve produce a central retinal or branch 
retinal artery occlusion or anterior ischemic optic neuropathy. 
Posterior optic neuropathy 
Injuries to the optic nerve posterior to the entrance and exit of the 
central retinal artery and vein produce no immediate change in the 
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appearance of the ocular fundus. Optic disc remains normal for at least 
three to five weeks, following which it becomes pale. The most common 
site of posterior indirect optic nerve injury is the optic canal. 
The intracranial optic nerve is the next most common site of 
injury, produce hemianopic field defect. If chiasm is injured it leads to 
bilateral injury. 
It is important to distinguish among injuries to the orbital, 
intracanalicular and intracranial portions of the optic nerve, because the 
treatment of injuries to the three different areas is quite different. 
The prognosis of an optic nerve injury depends on whether it is 
direct or indirect. Direct injuries tend to produce severe and immediate 
visual loss with little like hood of recovery. Indirect injuries are not 
infrequently associated with visual recovery and also produce delayed 
visual loss that occurs several hours to days after the injury. 
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PATHOPHYSIOLOGY 
The optic nerve axons lie in two compartments: the intradural and 
intrafascicular. Closed space edema, contusion necrosis, nerve fibre 
tears and infarction due to thrombosis or spasm have all been implicated 
as potential mechanisms of optic nerve injury. Shearing, stretching, 
compression and contusion at the level of intracanalicular optic nerve 
are the most important mechanisms in creating optic nerve dysfunction. 
Surgery can only open the dura and cannot relieve intrafascicular 
pressure elevations. Interruption of venous flow may also play a major 
role. Myelin is more sensitive to edema and acidosis than axonal 
structures. The typical findings found at autopsy include haemorrhage, 
demylination, focal necrosis and axonal changes.  
The exact pathophysiology of traumatic optic neuropathy is 
poorly understood. Although optic nerve avulsion and transection, optic 
nerve sheath hematoma, and optic nerve impingement (from a 
penetrating foreign body or bony fracture) all reflect traumatic 
mechanisms of the optic nerve dysfunction, these are less common 
forms of traumatic neuropathic vision loss. 
Traumatic optic neuropathy, in its most common form, is an 
indirect event that occurs during or shortly after blunt trauma to the 
superior orbital rim, lateral orbital rim, frontal area, or cranium. The 
most widely held belief maintains that compression forces from the 
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trauma are transmitted via the orbital bones to the orbital apex and optic 
canal. Laser interferometry studies demonstrate that forces applied to 
the frontal bone are concentrated and transferred to the orbital apex and 
anterior foramen of the optic canal. Elastic deformation of the sphenoid 
then allows transfer of the force to the intracanalicular segment of the 
optic nerve. Contusion of the intracanalicular optic nerve axons and pial 
microvasculature produces localized optic nerve ischemia and edema. 
The edematous ischemic axons result in further neural compression 
within the fixed-diameter bony optic canal, precipitate a positive 
feedback loop, and trigger the development of an intracanalicular 
compartment syndrome. 
Although ischemia is considered the secondary event that gives 
rise to the neuropathy, the cellular and subcellular events that constitute 
the mechanism of neural damage are only now being realized. The roles 
of oxygen free radicals, enzymes, cytokines, intracellular calcium, and 
other forms of reperfusion damage are slowly being uncovered through 
basic science research. 
A less common form of traumatic optic neuropathy that involves 
the intracranial optic nerve results from forces delivered by the brain's 
shift at the moment of impact. The intracranial optic nerve is sheared as 
it moves against the falciform dural fold as it overlies the sphenoid 
plane. 
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Histologic Findings 
Clinicopathologic studies, however, have demonstrated several 
features of traumatic optic neuropathy, as follows: 
• Blood within the optic nerve sheath  
• Interstitial optic nerve haemorrhage  
• Fibrosis of the pial septa  
• Lymphoplasmacytic infiltration  
• Iron-laden macrophages  
• Triangular-shaped axonal degeneration with loss of myelin  
• Ischemic necrosis 
The time-dependent histopathologic changes of the optic nerve 
following indirect trauma have not been adequately described. 
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                   NEURO-OPHTHALMIC EVALUATION 
The diagnosis of traumatic optic neuropathy is clinical. Patients 
with midfacial and cranial trauma should elicit a high index of suspicion 
for traumatic optic neuropathy. Although patients with traumatic optic 
neuropathy may have serious and obvious craniofacial, neurosurgical, 
and other co-morbidities, they may also have no visible signs of injury. 
In addition, although 50% of patients with traumatic optic neuropathy 
present with a visual acuity of light perception or no light perception, 
nearly 20% of patients have a visual acuity of 20/200 or better.  
Assume optic nerve dysfunction when a loss of best-corrected 
visual acuity or visual field is accompanied by an ipsilateral afferent 
papillary defect  (APD) (eg, Marcus Gunn pupil). Obtain a detailed 
medical history and identify premorbid ocular conditions that may limit 
vision recovery. If the patient's clinical situation limits detailed 
communication, query the patient's family, paramedics, or witnesses to 
the trauma about the details of the injury. 
Comprehensive ophthalmic examination on all patients in whom 
traumatic optic neuropathy is suspected is essential and include the 
following assessments: 
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• Ocular adnexa: Examination may reveal orbital rim and wall 
fractures, orbital edema, proptosis or enophthalmos, or 
extraocular muscle dysfunction. Signs of penetrating injuries, 
such as protruding foreign bodies, extruding orbital contents, or 
conjunctival laceration, may range from obvious to subtle.  
• Visual acuity: Assess visual acuity immediately upon 
presentation. Perform a second assessment within 24 hours of the 
first to discern cases of delayed optic neuropathy (<10% of 
traumatic optic neuropathy cases).  
• Pupillary reaction: An afferent pupillary defect is a necessary 
condition for the diagnosis of traumatic optic neuropathy. 
Pupillary reaction is evaluated with the swinging flashlight test 
(i.e., briskly alternating a flashlight beam from one eye to the 
other). An afferent pupillary defect is detected when the pupil's 
initial constriction is replaced by initial dilation.  
• Intraocular pressure: Increased intraocular pressure may 
accompany an orbital hematoma, diffuse orbital haemorrhage, 
orbital emphysema, or soft tissue edema.  
•  Ophthalmoscopy: Perform ophthalmoscopy with the aid of a 
short-acting mydriatic agent (pupillary dilation) on all stable 
patients. Evaluate the retinal and choroidal circulation, optic 
nerve head morphology, and the presence of ring-shaped 
haemorrhage adjacent to the optic nerve head. 
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Laboratory Studies 
• Haemostasis is essential during optic canal decompression. 
Obtain the following tests as suggested by the patient's medical 
history:  
o Hemoglobin/hematocrit  
o Platelet count  
o Prothrombin time (PT)/activated partial thromboplastin 
time (aPTT)  
o Bleeding time 
Imaging Studies 
Although most patients with posterior traumatic optic neuropathy 
have normal imaging studies, CT without contrast should be performed 
in all cases. Imaging will allow identification of associated fractures, 
optic nerve avulsion, optic nerve sheath hematoma and optic nerve 
compression due to orbital hematoma. 
Thin-slice CT scan of the nose, sinuses, orbits and optic canal 
o CT scanning provides adequate imaging of orbital soft tissue and 
is better than MRI at delineating bony defects. A thin-section CT 
scan also provides an intraoperative road map for the surgeon in 
patients who require surgical decompression.  
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o The decision for surgical decompression should still be based 
primarily on the clinical examination findings and not the CT 
scan findings. Small-review series have concluded that the extent 
of bony canal injury documented at surgery was underestimated 
by CT scan findings.  
o In polytraumatized patients with poor awareness, CT scan with 
clinical exploration is the most important method for the 
assessment of traumatic optic neuropathy in the acute emergency 
setting.  
o Fractures through the optic canal can be best depicted with 
thin-section CT scanning (eg, 1.5-mm cuts with 1-mm 
intervals). 
• Surgeons who wish to perform image-guided optic canal 
decompression need to obtain a special-order CT scan that is 
formatted to their computerized stereotactic localizing system. 
• Spiral CT allows rapid data acquisition in uncooperative adults 
and children. 
• MRI is only indicated if intracranial injuries are present that are 
inadequately detailed with CT imaging. 
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Other tests 
• Visual field perimetry: Patients suspected of sustaining 
traumatic optic neuropathy should undergo visual field testing. 
Although no visual field defects are pathognomonic of traumatic 
optic neuropathy, quantification of visual field defects is useful to 
assess convalescent visual improvements. Simple visual field 
screening can be accomplished at the bedside for unstable 
patients, but formally assess patients who can be evaluated in the 
clinic setting.  
• Multifocal visual-evoked potential (VEP), multifocal 
electroretinography (mfERG), and optical coherence 
tomography are 3 promising techniques in the future diagnoses 
of subclinical vision loss. Some of these tests are already used in 
neuroophthalmology for the studies of the retina and glaucoma. 
Although none of these techniques should replace a careful 
history and clinical examination, these techniques might be 
important as adjunct procedures in the evaluation of the 
unconscious patient or patients with bilateral optic 
neuropathy. Flash visual-evoked potential (FVEP) was studied in 
patients with traumatic optic neuropathy with calculation of a 
ratio of the amplitude of the injured to the uninjured eye. A ratio 
of greater than 50% was associated with favourable visual 
outcome. 
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NATURAL HISTORY 
The natural history of traumatic optic neuropathy is difficult to 
characterize because each patient is different.  Attempts to study patient 
outcomes have also been hindered by the assumption that corticosteroids 
are helpful and that not offering them would be unethical.  Visual 
prognosis and likelihood of spontaneous improvement are independent 
of the initial visual acuity. 
The natural history of indirect optic nerve injuries has been 
described in several clinical series.   The rate of spontaneous visual 
improvement ranges from 20% to 57% as shown in following table: 
  NATURAL HISTORY OF TRAUMATIC OPTIC NEUROPATHY 
Author(Year of 
Study) Number of patients 
Spontaneous 
improvement (%) 
Tang14 (1986) 13 38 
Millesi13 (1988) 07 57 
Lessell14 (1989) 25 20 
Seiff 7 (1990) 15 33 
Levin 6 (1999) 09 57 
 
Even patients who had a return of normal central visual acuity did 
not regain an entirely normal afferent examination.  Persistence of visual 
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field and colour defects, and APD are typical. Optic nerve pallor or 
nerve fibre layer changes also develop over the months following the 
injury.  Patients with  no light perception  (NLP) on presentation can 
sometimes recover useful vision without intervention. 
The prognosis tends to be better for patients who have a lucid 
interval or an enlarged nerve sheath but poorer for patients older than 40 
years. The following factors do not appear to correlate with visual 
outcome. 
• Gender 
• Level of consciousness 
• Mechanism of injury 
• Initial visual acuity (including NLP) 
• Presence of fractures (including optic canal fracture), and 
• Time from injury to intervention (within the first 7 d). 
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DIFFERENTIAL DIAGNOSIS 
With a thorough history and complete clinical examination, the 
differential diagnosis of visual loss with disturbed pupillary function can 
be narrowed. 
Monocular visual loss may not be noticed until the individual has 
occasion to close the uninvolved eye. In this setting patient may 
attribute the visual loss to a recent traumatic event. Deciding the visual 
loss is co-incidental or causal may be difficult. Any process that can 
result in visual loss may be co-incidental with a traumatic incident such 
as decomposition of a vascular aneurysm, orbital or optic nerve 
inflammation, anterior ischemic optic neuropathy or acute sinus disease 
with orbital involvement. A traumatic cavernous sinus fistula is usually 
accompanied by numerous orbital findings permitting easy 
differentiation from traumatic optic neuropathy. 
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TREATMENT 
During the mid 1970s, observation was replaced by steroid 
therapy and surgery as a variety of case series promoted the success 
rates of these improvement without treatment has been well 
documented.  Despite the rate of spontaneous improvement, however, 
the standard of care has been to offer high dose corticosteroids.  The 
role of surgical intervention is still debated.   The International Optic 
Nerve Trauma Study (published in 1999) demonstrated  no clear benefit 
from either corticosteroid therapy or optic canal decompression surgery.  
Observation has again become an acceptable option when  there is no 
evidence of intrasheath hematoma, orbital hematoma, or optic canal 
fracture fragments.  
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                                         Afferent Pupillary Defect 
                               Yes                                             No* 
Optic Nerve Swelling                  Bilateral TON    Retina    Other: 
           
     Yes          No                                                        Occipital lobe  
                                                                                                 Hyphema 
              Vitreous Hge 
Anterior TON                                     Posterior TON 
Neuroimaging                                      Neuroimaging 
Hematoma? 
Sheath   Orbital   None             Fracture     Fragment    Normal 
Visual acuity better than 20/40          Visual acuity worse than 20/40 
Observation                    Surgery                     Mega dose steroids* 
                       Vision stabilizes    Vision improves    Vision worsens 
                Continue steroids  Stop steroids       Surgery 
*Loading dose: I.V. Methyl prednisolone 30 mg/kg followed by 15 mg/kg 2 h later.  
The maintenance dose could then be 15 mg/kg at 6 h intervals or 5.4mg/kg/h for at 
least 48 h before deciding whether response has occurred.  TON-traumatic optic 
neuropathy 
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Corticosteroid Therapy 
Widely used for several decades, corticosteroids are thought to 
stabilize lipid membranes, reduce spasm, increase blood supply, and 
reduce neural tissue edema and necrosis. Mega dose steroids were first 
studied in animal models with brain edema and then in humans with 
spinal cord injuries.  Spoor11 and colleagues were the first to use spinal 
cord doses for patients with traumatic optic neuropathy.  They divided 
their patients into two groups, and treated 
• One group (13 patients) with methyl prednisolone (30 mg/kg 
initially, then 15 mg/kg given 2 h later and then in divided doses 
every 6 h) and 
• The second group (8 patients) with high dose dexamethasone (20 
mg every 6 h) 
Both therapies were continued for 48 hours, then followed by a 
rapid taper.  Of the treated eyes (one per patient), 17 of 21 (81%) 
improved in visual function during these protocols.  The relative dose of 
steroid was much higher for the methylprednisolone group, but the 
overall outcome was no different.  The methylprednisolone group 
appeared to make a more-rapid recovery, however.  A delay in treatment 
did not appear to alter outcome in this study.  The mean onset of therapy 
was 4.2 days.  The authors of the study believed that neither the initial 
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severity nor the type of nerve injury allowed the response to steroid 
therapy to be predicted, as five of eight eyes in this study initially had 
NLP but regained significant function. 
Another series by Bendel20 and colleagues described 17 patients 
treated with 2 g methylprednisolone initially, then 1 g, divided, every 6 
hours for 48 hours.  Vision improved in all patients, with an average 
pre-treatment vision of 20/100 and average post treatment vision of 
20/25.  Best vision occurred between 1 and 6 days after treatment (mean 
=2.9 d).  Three patients demonstrated deteriorating visual function 
during steroid taper and were treated with extracranial optic nerve 
decompression; all three had eventual improvement. 
Mauriello10 and colleagues reported a series in which 9 of 16 
patients (56%) treated with a more-conventional steroid dose had 
significant improvement (1 g loading dose, then 150 mg in divided 
doses every 6 h for 48 h).  Almost all patients who did not improve had 
NLP vision initially.  They also noted that all 5 of their patients with a 
lucid interval following injury had eventual improvement. 
In summary, a short course of high-dose steroid may be 
considered unless there is clear evidence of optic nerve transection or 
avulsion by clinical or radiographic criteria.  A delay in onset of therapy 
and the degree of visual loss have not been clearly shown to alter 
prognosis as evidenced by following table. 
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REPORTED OUTCOMES USING CORTICOSTEROIDS 
Author(Year of 
Study) 
Number of Patients 
and (Treatment 
Received)* 
Visual 
improvement (%) 
Tang14  (1986) 05(C) 
11(M) 
20 
36 
Millesi 13(1988) 02(U) 50 
Lessel4(1990) 04(U) 25 
Seiff7    (1990) 21(M) 62 
Spoor11  (1990) 22(M) 86 
Bendel20 (1993) 17(M) 100 
Levin6  (1999) 85(M) 52 
*C: conventional steroid dose (1 g methylprednisolone loading dose 
followed by 250 mg methylprednisolone qid). 
M: mega dose steroid doses ( 30 mg/kg methylprednisolone loading 
dose followed by 15 mg/kg every 6 h or 5.4 mg/kg/hr for 24—48 hrs ).  
U: Unspecified. 
Surgical intervention 
Optic canal decompression was first described in 1916, wherein a 
transcranial unroofing was performed in patients with afferent 
dysfunction who required craniotomies for other reasons.  Extracranial 
techniques were later described to minimize the possible complications 
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associated with craniotomy.   A transethmoidal approach was 
investigated as early as 1926 but not popularized until the 1960s.  
External, transantral, Caldwell-Luc, and transnasal approached have all 
been tried.  Comparison of different clinical series is difficult because of 
differences in techniques, selection criteria, and quantification of visual 
improvement.  Many patients also receive at least conventional doses of 
corticosteroids in the peri-operative period, further confusing the ability 
to attribute improvement to the surgical intervention.  The frequency of 
reported visual improvement ranges from 12% to 79%.  In many 
medical centres, the decision to operate is governed by the criteria 
established in 1966 by Walsh  
CRITERIA GOVERNING SURGICAL INTERVENTION IN 
PATIENTS WITH TRAUMATIC OPTIC NERUOPATHY 
Absolute Surgical Contraindication 
• Optic nerve avulsion is present on CT imaging 
Relative Surgical Contraindications 
• Patient is unconscious 
• Total loss of vision and pupillary response 
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Relative Surgical Indications 
• If visual loss develops despite steroid treatment 
• If visual decline occurs during the steroid taper 
• If an optic canal fracture is accompanied by potentially 
compressive bone fragment  
• If the visual evoked potential (VEP) response deteriorates 
over time 
Mauriello10 and colleagues treated 23 patient with steroids and 
operated on 7 nonresponders based on CT evidence of surgical 
pathology (optic nerve sheath enlargement or narrowing of the optic 
canal by bone spicules).  Of the 3 patients treated with optic nerve 
sheath fenestration alone, only 1 had significant improvement.  The 
remaining 4 patients were treated with both fenestration and optic canal 
decompression.  Only 1 patient had significant improvement (NLP to 
20/200). 
Joseph30 and colleagues reported visual improvement in 11 of 14 
patients treated with steroids and transethmoidal decompression of the 
optic canal.  This report was a retrospective review and not compared to 
any large, steroid-only treatment group, but the results are similar to 
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those in the study of Spoor and colleagues, who used mega dose 
corticosteroids. (described above). 
Levin6 and colleagues reported the outcome of the International 
Optic Nerve Trauma Study in 1999.  The goal of this endeavour was to 
compare the visual outcome of traumatic optic neuropathy treated with 
corticosteroids, treated with optic canal decompression surgery, or 
observed without treatment.  Patients who were randomized to the 
surgical group did not receive steroids in the peri operative period.  
Intervention occurred within the first 7 days following injury.  The main 
outcome measure was defined as visual acuity improvement of three or 
more lines of Snellen acuity.   The international Optic Nerve Trauma 
study found that only 32% in the surgery group ( n=32 ) improved 
significantly.  This was in contrast to the visual improvement observed 
in the untreated group ( 57%,  n=9 ) and steroid group ( 52%, n=85 ).  
The study concluded that there was no clear benefit for intervention.  In 
addition, they confirmed the findings of others that the timing of 
corticosteroids or surgery within the 7-day window did not affect 
outcome. 
  36
SUMMARY 
Traumatic optic neuropathy is a rare but significant  cause of post 
traumatic visual loss.  The responsible blunt trauma to the frontal region 
may be minor or severe and accompanied by multiple adjacent fractures.  
Careful documentation of visual acuity, pupillary function, and red 
desaturation is essential to guide management.  CT imaging should be 
performed to document such structural abnormalities as optic nerve 
avulsion, optic nerve sheath hematoma, orbital hematoma, or optic canal 
fracture with fragments.  
Based on the data from the International Optic Nerve Trauma 
Study, observation without intervention is a viable option.  Patients and 
their families should be made aware of the information regarding mega 
dose corticosteroid therapy and participate in an informed decision.  In 
particular, if visual acuity begins to deteriorate, then corticosteroid 
therapy should be considered.  If a structural abnormality is present that 
may be contributing to optic nerve dysfunction (hematoma or fragment) 
or if the patient’s visual acuity deteriorates on corticosteroids, optic 
canal decompression should be offered.  Management of this disorder 
remains very controversial; involvement of other appropriate 
subspecialists and careful discussions with the patient and family are 
essential to maximize visual outcome. 
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FUTURE AND CONTROVERSIES 
 
A better understanding of the cellular and biochemical 
mechanisms involving normal and traumatized axons, glia, and myelin 
sheaths may eventually leads to better intervention for traumatic optic 
neuropathy. Although corticosteroids are a type of neuroprotective 
agents, the recent expansion in basic scientific research regarding other 
neuroprotective agents may lead to a redirection in future therapy for 
this condition. 
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AIM AND OBJECTIVES 
 
         To analyse the clinical profile, response to mega dose steroid 
therapy and visual function outcome in patients with traumatic optic 
neuropathy presenting to the neuroophthalmology clinic at regional 
institute of ophthalmology and government ophthalmic hospital Chennai 
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MATERIALS AND METHODS 
A prospective observational case study on the pattern of traumatic 
optic neuropathy and analysis of clinical profile, response to treatment 
and visual function outcome was conducted in the department of 
neuroophthalmology at RIO-GOH, Chennai. 
The study was conducted from June 2008 to November 2010. All 
eligible traumatic optic neuropathy patients according to inclusion 
criteria, presented to the neuroophthalmology clinic at RIO-GOH during 
June 2008 to may 2010 were included in the study. The patients were 
followed up till November 2010. 
INCLUSION CRITERIA 
H/o impact to head and orbit  
Reduced BCVA in one eye 
Relative afferent pupillary defect  
Defective colour vision 
       Field defects 
      Fundus changes – Normal / Partial / Total optic atrophy 
      Associated extra ocular muscle palsy 
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EXCLUSION CRITERIA 
Major head injury 
   Unconscious patients 
Eyes with penetrating trauma  
  Candidates for decompression surgery 
Clinical features requiring neurological / neurosurgical 
interventions. 
CLINICAL EVALUATION OF CASES 
All cases referred to neuroophthalmology clinic either from 
general ophthalmic outpatient department, neurological, neurosurgical, 
general medicine department, who have decreased visual acuity 
following impact on head / orbit were evaluated in detail. An informed 
consent was taken from all eligible patients for inclusion in the study. 
The patient particular like name, age, sex, address, were 
documented. A detail history regarding the cause of blindness like time 
and nature of the trauma, level of consciousness after trauma, site of 
injury, onset and duration of symptoms and time of presentation, were 
noted. 
The patients were also enquired about h/o systemic illness or 
surgical instruments if any eg. Sinus or cranial surgeries which could 
influence the diagnosis. 
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A patient presented to the neuroophthalmology clinic has to 
undergo routine  
1. visual acuity  
2.  refraction 
3. pupillary reaction 
4.  slit lamp examination  
5.  fundus and tonometry examination 
6.  colour vision 
7.  field of vision 
8.  extra ocular movements were checked whenever necessary 
and possible. 
If visual acuity is poor or patient is un co-operative projection 
field or at least confrontation field, have been assessed. 
           X – ray skull lateral view, orbit PA view, CT orbit with optic 
canal axial and coronal, CT brain plain and contrast were taken when 
found necessary and possible. 
Cases were referred to neurology / ENT /orbit department in view 
of surgical management if required. 
           Patient’s visual acuity, pupillary reaction, colour vision, visual 
field and fundus were assessed during follow-up examination at one 
month, three months, six months and one year.  
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ANALYSIS 
Analysis of the collected data was done based on the following 
1. Incidence  
2. Age and sex distribution  
3. Mode of injury : 
RTA / fall / others 
4. Onset of symptoms :  
Immediate (within 24 hours) / 24 hours to one month / late (>1 
month) 
5. Time of presentation : 
        Within one week / 1 week to 1 month  / 1 month to 3 month / > 3 
month  
6. Presenting visual acuity                                                                                             
a) No PL / PL /HM 
b) 1/60 – 3/60 
c) 4/60 – 6/60 
d) 6/36 – 6/18 
e) 6/12 – 6/6 
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7. Site of injury:   
Eye brow / fore head / side of face /other parts  
Skull and orbit  
8. Fundus status:  
Normal / abnormal 
9. Radiological finding: 
Normal / abnormal 
10. Treatment: 
           Observation / oral steroids / parentral steroids/ surgery 
11. Visual acuity at follow up:  
Static / improved / deteriorated. 
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RESULTS 
Based on exclusion and inclusion criteria 100 cases were taken up for 
the study. 
Demography :-  
Incidence :- 
Total No. of neuroophthalmic cases in the 
study period 
1923 
No. of traumatic optic neuropathy cases 100 
 
From the table it can be seen that traumatic optic neuropathy 
constituted about 5.2 % of the neuroophthalmology cases within the 
specified period of study. 
AGE DISTRIBUTION OF CASES 
Minimum Maximum Mean 
12 52 30.22 
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AGE GROUP 
Age group Frequency Percentage 
0 – 10 0 0 
11 – 20 14 14% 
21 – 30 44 44% 
31 – 40 26 26% 
41 – 50 15 15% 
51 – 60 1 1% 
>60 0 0 
     
In our study 70% belonged to the age group  20 – 40yrs. The 
minimum age was 12yrs and the maximum age was 52 yrs. The mean 
age was 30.22yrs with SD of 9.28. 
Age  Distribution 
0
14
44
26
15
1 0
0
5
10
15
20
25
30
35
40
45
50
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Age Group 
N
o 
of
 P
at
ie
nt
s 
 
  46
THE GENDER 
Gender Frequency Percentage 
Male 96 96 
Female 4 4 
Out of 100 patients, 96 were male (96%), 4 were female (4%) 
The gender 
96%
4%
Male
Female
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THE LATERALITY 
Laterality Right eye Left eye 
Frequency 56 44 
Percentage 56% 44% 
 
Of the 100 patients 56% of them had involvement of right eye and 
44% of them had involvement of left eye. 
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MODE OF INJURY 
Mode of injury No of cases Percentage 
RTA 65 65% 
Fall 19 19% 
Others 16 16% 
Motor vehicle and bicycle accidents for the majority of cases 
(65%) followed by fall (19%) and others. 
65%
19%
16%
0
10
20
30
40
50
60
70
Mode of injury
RTA
Fall
Others
 
 
  49
ONSET OF SYMPTOMS 
Immediate < 1 week 96% 
Late > 1 week  4% 
 
Majority of cases are immediate onset of visual symptoms (96%). 
Only 4% of cases presented with late onset of visual symptoms, this is 
because they would have developed the visual symptoms early but 
might have only noticed it later. 
Onset of symptoms
96%
4%
Immediate
Late
 
 
 
  50
SITE OF INJURY 
site of injury eye brow fore head side of face not known 
no of cases 33 52 9 6 
percentage 33% 52% 9% 6% 
Fore head was the common site of injury (52%) followed by eye 
brow (33%) and side of face (9%).  
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TIME OF PRESENTATION 
TIME OF 
PRESENTATION 
NO OF CASES PERCENTAGE 
0 – 1 week 49 49% 
1 week to 1 month 23 23% 
1 – 3 months 24 24% 
>3 months 4 4% 
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PRESENTING VISUAL ACUITY 
VISUAL ACUITY FREQUENCY PERCENTAGE 
NO PL 27 27% 
PL+  20 20% 
HM - CFCF 23 23% 
1/60 – 3/60 14 14% 
4/60 -6/60 8 8% 
>6/60-6/18 8 8% 
 
About 27% of patients had no light perception to light perception 
at the time of presentation. However 8% of patients had better than 6/60 
at presentation. 
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OPTIC NERVE HEAD STATUS 
Fundus Frequency Percentage 
Normal 57 57% 
Pale disc 28 28% 
Partially pale 15 15% 
57% of patients had normal disc. 28% of patients had full pallor 
of disc and about 15% had partial pallor at the time of presentation.    
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RADIOLOGICAL FINDINGS 
 No of Patients Percentage 
Abnormal 45 45% 
Normal 55 55% 
 
About 55% of cases presented without any radiological 
abnormality or fracture.45% had associated orbital, cranial or facial 
bone fractures evident radiologically. 
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TREATMENT 
 Frequency percentage 
observed 27 27% 
Oral steroids 22 22% 
Parenteral steroids 50 50% 
surgery 1 1% 
In 100 cases 27 cases were observed 22 cases were treated with 
oral steroids, 50 cases were given parenteral steroids followed by oral 
steroids. One case treated with endoscopic optic nerve decompression. 
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VISUAL OUTCOME 
 No. of Patients Percentages 
Static 73 73% 
Improved 25 25% 
Deteriorated 2 2% 
 
In the 100 cases only 25 cases showed improvement in visual 
function (three lines increase in VA in Snellen VA chart), 73 cases had 
static (patients with no improvement [69] and those with < three lines 
improvement [4]) and 2 cases had deteriorated visual function, both had 
poor VA at the time of presentation.  
Visual outcome
73%
25%
2%
static
improved
deteriorated
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VISUAL OUTCOME WITH STEROID THERAPY 
 No of pts treated 
No of pts 
showed 
improved VA 
Percentage 
Steroid 72 23 31.94% 
surgery 1 1 100% 
Observed  27 1 3.70% 
Out of 72 patients treated with corticosteroid (oral-22, parentral-
50) only 23 patients (31.94%) showed visual improvement (oral-3, 
parentral-20). One patient who presented 1 month after injury had  
fracture medial wall of optic canal treated with endo nasal optic nerve 
decompression showed visual improvement from 4/60 to 6/36. 
steroid gp
 surgery gp
observed gp
0
20
40
60
80
100
visual outcome 
pts treated
pts showed imp
percentage
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VISUAL IMPROVEMENT DEPENDING ON 
PRESENTING VISUAL ACUITY 
 NO OF PTS PRESENTED 
NO OF PTS 
SHOWED 
IMP 
PERCENTAGE
No PL to HM 70 5 7.14% 
1/60-3/60 14 7 50% 
4/60-6/60 8 5 62.50% 
6/36-6/18 8 8 100% 
Among 100 patients 8 patients had VA > 6/60 and all showed 
improved visual function with treatment. 
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FOLLOW UP 
 Percentage  
Observed group 29% 
Treated group 43% 
 
Only 43% of treated group and 29% of observed group had come 
for follow up examination. 
 
   Follow up
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DISCUSSION 
Hippocrates might have been the first to identify the phenomenon 
of acute and delayed vision loss after injuries placed to and slightly 
above the brow. While there is little controversy on the macroscopic 
mechanism of trauma theory, multiple hypothesis have been proposed at 
microscopic level of damage to the optic nerve including contusion 
necrosis, nerve fibre tears and nerve infarction secondary to closed 
space edema, haemorrhage, thrombosis, vasospasm, impingement by 
bone spicules and shearing of dural vessels in the optic canal. 
In our study it is evident that traumatic optic neuropathy is  
devastating cause of permanent visual loss. Concussive force to head 
especially forehead transmits shock wave to optic canal. Visual loss is 
usually instantaneous.  
Blunt trauma, penetrating injuries and self mutilation are the most 
common causes of optic nerve injury. Blunt trauma classically occurs 
following rapid deceleration injuries to the anterofrontal region of the 
head. Trauma to the outer third of the supraorbital rim is transmitted 
directly to the optic canal, where the optic nerve is tethered at both ends 
by dura. Conversely, the optic nerve is not taut in the orbit and protected 
by orbital fat and resistant to injury at this site.    
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The severity of the trauma does not always correlate with the 
visual loss. Incidents such as minor fall after tripping or hitting the side 
of the head against a solid object resulting in a frontal blow are adequate 
to produce a posterior traumatic optic neuropathy. The most common 
mechanism of injury is motor cycle accidents. Most of them are solo 
spills. Also the presence of or severity of the orbital fractures neither 
directly predicts the severity of visual loss nor determines the prognosis. 
Fracture of the medial orbital wall, floor, zygoma or optic canal may be 
present. One patient of optic canal fracture may regain normal vision 
without intervention but another with no fracture may present with no 
light perception that persists despite all intervention. Traumatic optic 
neuropathy is most often seen in young males in their 2st or 3nd decades 
of life. In one study, 5 patients older than 40 years of age were found to 
have a worse visual outcome independent of the mechanism of injury, 
severity of the visual loss or the interventions utilized.  
Visual deficits range from mild decrease in visual acuity with 
subtle field defect to complete loss of light perception.  In most cases, 
the visual loss is severe and instantaneous. Even seemingly trivial 
trauma may result in dramatic optic nerve impairment. The severity of 
the visual loss does not necessarily correlate with the degree of overall 
trauma.  
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Visual evoked potentials (Flash) have limited utility and may give 
false negative results prior to the onset of optic neuropathy. Although 
most patients with traumatic optic neuropathy have normal imaging 
studies, CT without contrast should be performed in all cases. Spiral CT 
allows rapid data acquisition in uncooperative adults and children. Even 
though fundus examination will reveal the following, imaging will allow 
identification of associated fractures, optic nerve avulsion, transection, 
optic nerve sheath hematoma and optic nerve compression due to an 
orbital hematoma. The optic nerve injury may not be isolated. 
Associated fractures and injuries can be identified when the scope of 
evaluation is expanded to include otolaryngology, oral, maxillofacial 
and neurosurgery colleagues. Magnetic resonance imaging is only 
indicated if intracranial injuries are present that are inadequately 
detailed with CT imaging. However concurrent orbito-facial fractures, 
extraocular nerve palsies and type of injury have no relevance to the 
final visual results.  
This current study was carried over a period of 2 years,  
consecutive 100 patients were selected to determine the pattern of 
disease in a tertiary care centre like our institute.  According to a study 
by  Tang14 (1986),  out of 11 patients 36% showed visual improvement 
following maga dose steroid. In our study, 31.94% of the patients 
treated with steroids showed visual improvement. Analysing the 
demographic details in our study it is seen that most of our patients 
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(70%) were 20-40 years of age. Male patients were predominant in the 
study. This correlates with the higher rate of motor cycle accidents as 
the etiology. TON is a significant cause of post traumatic visual loss. 
The responsible blunt trauma to the frontal region may be minor or 
severe and accompanied by multiple adjacent fractures. Careful 
documentation of visual acuity, pupillary function and red desaturation 
is essential to guide management. CT imaging should be performed to 
document such abnormalities such as optic nerve avulsion, optic nerve 
sheath hematoma, orbital hematoma and optic canal fracture with 
fragments. If a structural abnormality is present  or if the patient’s visual 
acuity deteriorates on steroids, optic nerve decompression should be 
offered. Management of this disorder remains very controversial. In 
summary, a short course of high-dose steroid may be considered unless 
there is clear evidence of optic nerve transection or avulsion by clinical 
or radiographic criteria.   
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CONCLUSION 
In our study the clinical profile of 100 eligible patients who 
presented with loss of vision following trauma during June 2008 – May 
2010 were analyzed. 
1. The age distribution of the patients were such that maximum no. 
of patients (70%) were in the age group of 20-40 years. 
2. Males contributed 96 % while females contributed 4 % 
3. The major etiology in our study was road traffic accident (65%) 
followed by falls (19%) and then assaults or other modes of injury 
(16%) 
4. Most of the patients presented with Grade A visual loss. i.e. no 
PL to HM 
5. In most cases development of visual symptoms after trauma was 
instantaneous. 
6. Trauma around the eyebrow or frontal region was the commonest 
site of injury. 
7. Most of the cases presented within 1 month from the onset of 
symptoms after trauma. 
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8. In most cases, optic disc was normal (57%) although some (28 %) 
had pale optic disc at presentation.  
9. Of the 100 patients only 25% of them showed visual recovery to 
some degree with or without treatment. 
10.  Nearly 73% of them were left with permanent loss of vision. 
11.  About 2% of patients showed deteriorating visual outcome 
despite treatment. 
12.  Out of 72 patients treated with corticosteroid, only 23 patients 
had shown visual improvement (31.94%).  
13. All the patients who presented with grade D (6/36 – 6/18) visual 
acuity showed visual improvement. 
Considering the overall picture, it is evident that TON takes 
important place in permanent loss of vision in young males. Current 
clinical evidence is not sufficient to suggest the treatment option. Future 
developments in this field require randomised controlled clinical trials 
with extensive follow up to decide the treatment option. However it is 
evident that RTA especially two wheelers are at a particular risk and the 
incidence can be reduced by promoting education of riders to wear  
helmets. 
PREVENTION IS BETTER THAN CURE 
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PROFORMA 
Analytical study of 100 cases of traumatic optic neuropathy        Study No.  
Name:  
Op / Ip No: 
Age:  
Gender:   1. Male / 2. Female  
Date of examination: 
Laterality:    1. RE / 2. LE 
Mode of injury:     1. RTA / 2. Fall /  3. Others 
   If others, specify: 
Onset of symptoms:    days 
Time of presentation:  days 
Presenting VA:   BCVA: 
Site of injury:   1. Eye brow 
                                                 2. Forehead 
     3. Side of face 
     4. Other parts of skull 
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Pupillary reaction:   1.  1. Normal 
      2. RAPD 
Fundus status:   1.      1. Normal  
      2. Abnormal 
If abnormal, specify: 
Associated EOM Palsies:   1. Present 
      2. Not Present 
Colour Vision:    1. Normal 
      2. Defective 
Field defects:    1. Not present 
      2. Present 
   If present, specify: 
Treatment:  1.Observed  
   2. Oral steroids 
   3. Parenteral steroids 
                         4. Surgery 
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Follow Up Examination: 
1st follow up: 
 Date of follow up: 
 VA at follow up:   BCVA: 
 Status of VA:   1. Static 
      2. Improved 
      3. Deteriorated 
 Pupillary reaction:   1. Normal 
      2. RAPD 
 Fundus status:   1.     1. Normal  
              2. Abnormal 
If abnormal, specify: 
Colour Vision:           1. Normal 
      2. Defective 
Field defects:    1. Not present 
      2. Present 
   If present, specify: 
 
 
  74
2nd Follow up: 
         Date of follow up: 
 VA at follow up:   BCVA: 
 Status of VA:   1. Static 
      2. Improved 
      3. Deteriorated 
 Pupillary reaction:   1. Normal 
      2. RAPD 
 Fundus status:    1. Normal  
      2. Abnormal 
If abnormal, specify: 
Colour Vision:            1. Normal 
      2. Defective 
Field defects:    1. Not present 
      2. Present 
   If present, specify: 
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3rd follow up: 
        Date of follow up: 
 VA at follow up:   BCVA: 
 Status of VA:   1. Static 
      2. Improved 
      3. Deteriorated 
 Pupillary reaction:   1. Normal 
      2. RAPD 
 Fundus status:   1. Normal  
      2. Abnormal 
If abnormal, specify: 
Colour Vision:            1. Normal 
      2. Defective 
Field defects:    1. Not present 
      2. Present 
   If present, specify: 
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4th follow up:  
        Date of follow up: 
 VA at follow up:   BCVA: 
 Status of VA:   1. Static 
      2. Improved 
      3. Deteriorated 
 Pupillary reaction:   1. Normal 
      2. RAPD 
 Fundus status:   1. Normal  
      2. Abnormal 
If abnormal, specify: 
Colour Vision:            1. Normal 
      2. Defective 
Field defects:    1. Not present 
      2. Present 
   If present, specify: 
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KEY TO MASTER CHART 
ALT ALTITUDINAL FIELD DEFECT 
BCVA BEST CORRECTED VISUAL ACUITY 
CC CENTROCAECAL SCOTOMA 
CFCF COUNTING FINGER CLOSE TO FACE 
EB EYEBROW 
EBS ENLARGEMENT OF BLIND SPOT 
EOM  EXTRA OCULAR MUSCLE PALSIES  
FH FORE HEAD 
HM HAND MOVEMENT 
IP IN PATIENT 
LE LEFT EYE 
MOI MODE OF INJURY 
N NORMAL 
NI NO IMPROVEMENT 
NP NOT POSSIBLE 
OBS OBSERVATION 
OND OPTIC NERVE DECOMPRESSION 
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OP  OUT PATIENT 
OPS OTHER PART OF SKULL 
OS ORAL STEROID 
PCS PARA CENTRAL SCOTOMA 
PL PERCEPTION OF LIGHT 
PRE PRESENT 
PS PARENTRAL STEROID 
RAPD RELATIVE AFFERENT PUPILLARY DEFECT 
RE RIGHT EYE 
RTA ROAD TRAFIC ACCIDENT 
SF SIDE OF FACE 
TF TUBULAR FIELD 
UTQ UPPER TEMPORAL QUADRANTANOPIA 
VA VISUAL ACUITY 
 
 
                                      
 
 LIST OF SURGERIES 
S.No Name 
Age/ 
sex 
IP No Diagnosis Procedure 
1. Vasantha 50/F 430987 RE MC/LE Aphakia RE ECCE 
2. Jinna 65/M 431090 BE IMC LEECCE/PCIOL 
3. Jabastin 59/M 425152 RE PCIOL/LE MC LE ECCE/PCIOL 
4. Indurani 45/F 435162 RE IMC/LE MC LE ECCE/PCIOL 
5. Kasthuri 60/F 436477 BC IMC LE SICS/PCIOL 
6. Thatchayini 40/F 436693 RE MC/LE IMC RE ECCE/PCIOL 
7. Eswari 50/F 436946 RE MC/LE IMC RE ECCE/PCIOL 
8. Shanmugam 65/M 437265 BE IMC RE SICS/PCIOL 
9. Subbulakshmi 55/F 437251 BE NC RE SICS/PCIOL 
10 Thara 62/F 437555 BE NS LE>RE LE SICS/PCIOL 
11 Gowri 55/F 437681 RE IMC/LE PCIOL RE SICS/PCIOL 
12 Backiam 45/F 437768 LE Phacolyticglaucoma LE SICS/PCIOL 
13 Rajamannar 65/M 437556 BE PSCC LE SICS/PCIOL 
14 Chokkalingam 54/M 437994 RE PCIOL/LE MC LE SICS/PCIOL 
15 Kamsala 55/F 438261 RE MC/LE PCIOL RE SICS/PCIOL 
 S.No Name 
Age/ 
sex 
IP No Diagnosis Procedure 
16 Soodamani 70/F 439012 BE IMC RE>LE LE SICS/PCIOL 
17 Kamarbanu 64/F 439118 RE PCIOL/LE IMC LE Phaco/PCIOL 
18 Devaraj 64/M 439234 BE IMC LE Phaco/PCIOL 
19 Lakshmi 60/F 51267 LE Pterygium Excision with autograft 
20 Shankar 22/M 53142 RE Chalazion Incision & curettage 
21 Kalyani 50/F 53763 RE Pterygium Excision with AMG 
22 Meenatchi 55/F 438654 RE Post traumatic endophthalmitis Intravitreal amikacin 
23 Rajendren 45/M 439387 LE Non healing fungal corneal ulcer LE Theraputic keratoplasty 
24 Lalitha 54/F 438769 RE fungal corneal ulcer RE AC wash with Amphotericin B 
25 Rajesh 60/M 56375 RE chronic dacryocystitis RE Dacryocystectomy 
26 Gejalakshmi 38/F 439432 RE Facial palsy RE Lateral Tarsorrhaphy 
27 Ramani 66/F 435267 RE Upper lid abscess Incision & drainage 
28 Saradha 22/F 439765 LE post traumatic panophthalmitis LE Evisceration  PMMA implant 
29 Narayanan 58/M 439897 LE Secondary glaucoma LE trabeculectomy 
30 Ramya 23/F 439989 LE Sensory exotropia LE LR recession MR resection 
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1 Anand 425412 27 M 13.6.08 RE RTA 1 1 HM+ NI EB 2 RAPD Normal NP NP
#lat wall of orbit, #zygoma, 
#maxilla, #frontal PS
2 Gunasekar 85855 21 M 21.6.08 LE RTA 1 3 No PL NI FH 2 RAPD pale disc NP NP N OBS
3 Shankar 86723 27 M 28.6.08 LE assault 1 3 1/60. NI FH 2 RAPD pale disc RAPD NP N OBS
4 Baskar 87434 43 M 4.7.08 RE RTA 1 2 CFCF NI FH 2 RAPD Normal NP NP N OS
5 Munuswamy 88256 30 M 16.7.08 RE RTA 1 3 No PL NI FH 2 RAPD pale disc NP NP #floor of orbit OBS
6 Kajendren 425526 44 M 22.7.08 LE Fall 1 3 No PL NI FH 2 RAPD Normal NP NP N OBS
7 Siva 426114 25 M 30.7.08 RE RTA 1 1 HM+ NI EB 2 RAPD Normal NP NP N PS
8 Srinivasan 426664 14 M 1.8.08 RE Fall 1 3 No PL NI FH 2 RAPD pale disc NP NP N OBS
9 Nagendren 429760 28 M 12.8.08 LE Fall 2 1 No PL NI EB 2 RAPD Normal NP NP #medial wall orbit PS
10 Rajesh 430103 35 M 17.8.08 LE RTA 1 3 CFCF NI SF 2 RAPD pale disc NP NP N OBS
11 Ravi 88948 30 M 12.09.08 RE RTA 1 2 No PL NI EB 2 RAPD pale disc NP NP N OS
12 Ethiraj 89309 30 M 14.9.08 LE RTA 1 4 1/60. NI FH 2 RAPD pale disc NP NP N OBS
13 Mani 89648 30 M 19.9.08 RE Fall 1 3 No PL NI EB 2 RAPD temporal pallor NP NP N OBS
14 Kathirvel 433856 36 M 29.9.08 RE RTA 1 1 6/60. 6/36. OPS 2 RAPD Normal RAPD CC #lat wall of rt. orbit , #zygoma PS
15 Parasuraman 433923 33 M 3.10.08 RE RTA 1 3 PL + NI FH 2 RAPD pale disc NP NP N OBS
16 Anbu 433345 16 M 13.10.08 RE RTA 1 1 PL + NI FH 2 RAPD temporal pallor NP NP #maxilla PS
17 Azhagesan 433521 38 M 19.10.08 LE RTA 1 3 5/60. 6/18. FH 2 RAPD temporal pallor RAPD TF N OBS
18 Iyyappan 89876 36 M 24.10.08 RE injury with ball 1 4 CFCF NI EB 2 RAPD temporal pallor NP NP N OBS
19 Babu 434274 38 M 2.11.08 RE Fall 1 1 1/60. 6/24. FH 2 RAPD Normal RAPD N N PS
20 Ranjithkumar 89930 17 M 5.11.08 RE RTA 1 4 No PL NI OPS 2 RAPD temporal pallor NP NP N OBS
21 Thanikachalam 434328 49 M 6.11.08 RE Fall 1 1 HM+ 6/18. SF 2 RAPD Normal RAPD TF N PS
22 Mujibullah 434822 23 M 16.11.08 RE RTA 1 1 PL + 1/60. FH 2 RAPD Normal NP NP N PS
23 Baskar 90172 30 M 4.12.08 LE assault 1 1 6/24. 6/9P SF 2 RAPD Normal RAPD N #lateral wall of orbit PS
24 Krishnan 436158 42 M 7.12.08 RE RTA 2 2 HM+ NI EB 2 RAPD Normal NP NP N OS
25 Mahendren 439032 16 M 18.12.08 RE RTA 1 1 6/60. 6/24. FH 2 RAPD Normal RAPD N #sphenoid PS
26 Selvam 90259 33 M 31.12.08 LE RTA 1 3 No PL NI SF 2 RAPD pale disc NP NP #lat.wall OBS
27 Kannan 439428 30 M 2.1.09 LE RTA 1 1 No PL NI FH 2 RAPD pale disc NP NP #lat.wall PS
28 Baskar 90365 30 M 14.1.09 RE RTA 1 3 HM+ NI EB 2 RAPD pale disc NP NP
, g g
sphenoid, #frontal, #temporal OBS
29 Murugan 439965 42 M 24.1.09 LE assault 1 1 CFCF NI EB 2 RAPD temporal pallor NP NP #roof PS
30 Gowri 443457 50 F 31.1.09 LE hit on wall 1 1 CFCF NI FH 2 RAPD Normal NP NP N PS
31 Selvaprakash 443800 25 M 1.2.09 RE RTA 1 1 No PL NI FH 2 RAPD Normal NP NP bone PS
32 Lakhmi 443885 35 F 6.2.09 LE Fall 1 1 1/60. 6/9. FH 2 RAPD Normal NP NP N PS
33 Jeevanandham 445132 29 M 8.02.09 LE RTA 1 2 PL + 1/60. SF 2 RAPD Normal RAPD ALT 
p yg
#maxilla PS
34 Mani 445157 40 M 27.2.09 RE RTA 1 1 HM+ NI EB 2 RAPD Normal NP NP # Rt lat.wall, # rt.zygoma PS
35 Sivagnanam 445206 35 M 5.3.09 RE RTA 2 1 PL + 6/24. FH 2 RAPD Normal NP NP N PS
36 Kuselan 445249 50 M 7.3.09 RE RTA 1 2 PL + NI EB 2 RAPD Normal NP NP
#greater wing,# rt zygoma, # 
maxilla OS
37 Tamilvanan 445385 30 M 22.3.09 LE Fall 1 1 6/18. 6/6. FH 2 RAPD Normal RAPD N #medial, lateral, floor of orbit PS
38 Moorthy 445770 39 M 30.3.09 LE RTA 1 1 2/60. 6/18. EB 2 RAPD pale disc RAPD N N PS
39 Koteeswaran 445875 25 M 10.4.09 RE RTA 1 1 No PL HM+ FH 2 RAPD Normal NP NP
#Frontal, temporal, greater 
wing sphenoid bone PS
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40 Mohan 446453 32 M 10.4.09 RE RTA 1 1 6/60. 6/6. EB 2 RAPD Normal N N N PS
41 Ramachandren 446478 27 M 24.4.09 LE assault 1 1 No PL NI EB 2 RAPD pale disc NP NP #roof PS
42 Muralidharan 90457 32 M 25.4.09 LE RTA 1 3 PL + NI FH 2 RAPD pale disc NP NP N OBS
43 Karthick 90514 21 M 3.5.09 RE RTA 1 2 PL + NI EB 2 RAPD Normal NP NP N OS
44 Sathish 449429 22 M 24.5.09 RE RTA 1 2 6/36. 6/12. OPS 2 RAPD Normal RAPD PCS
#orbit inf & lat wall, # maxilla, 
# zygoma, # temporal bone OS
45 Kannan 90589 26 M 28.5.09 RE RTA 1 3 No PL NI FH 2 RAPD pale disc NP NP N OBS
46 Bazheer ahmad 90598 39 M 30.5.09 LE Fall 1 2 6/36. 6/9P EB 2 RAPD Normal RAPD N
#roof, #maxilla, #zygoma, 
#temporal bone OS
47 Uvaraj 449473 14 M 1.6.09 LE Fall 1 1 6/24. 6/6P FH 2 RAPD Normal RAPD ALT N PS
48 Umanandam 449891 14 M 6.6.09 LE
hit against 
wall 1 3 No PL NI EB 2 RAPD pale disc NP NP N OBS
49 Mubarak 90624 26 M 15.6.09 RE RTA 1 3 1/60. NI OPS 2 RAPD pale disc RAPD NP
#lat.wall,#greater wing of 
sphenoid, #zygoma, 
#temporal bone OBS
50 Chandren 449891 26 M 17.6.09 LE RTA 1 2 3/60. NI FH 2 RAPD Normal RAPD UTQ N OS
51 Mani 449900 43 M 18.6.09 LE assault 1 2 6/18. 6/6P EB 2 RAPD Normal RAPD N retrobulbar haemorrhage OS
52 Ramesh 90772 30 M 8.7.09 RE Fall 1 2 CFCF NI FH 2 RAPD Normal NP NP #lat wall OS
53 Sivakumar 90870 32 M 14.7.09 RE assault 2 3 PL + NI SF 2 RAPD pale disc NP NP N OBS
54 Paramasivam 450989 37 M 19.7.09 LE RTA 1 2 No PL NI FH 2 RAPD temporal pallor NP NP #frontal bone OS
55 Anandhan 451100 42 M 22.7.09 LE RTA 1 3 No PL NI EB 2 RAPD pale disc NP NP N OBS
56 Tamilselvan 451478 22 M 26.7.09 LE assault 1 1 2/60. 6/60. FH 2 RAPD Normal RAPD ALT
#medial, lateral, roof of orbit, 
#maxilla, #zygoma, #frontal 
bone PS
57 Jagajeevanram 91489 45 M 26.7.09 LE RTA 1 2 CFCF NI EB 2 RAPD Normal NP NP
#frontal,#temporal,#maxilla,#r
oof,#sphenoid OS
58 Durga 451552 17 F 6.8.09 RE RTA 1 3 PL + NI FH 2 RAPD pale disc NP NP optic nerve edema OS
59 Hemraj 451614 27 M 9.8.09 RE RTA 1 1 HM+ NI EB 2 RAPD Normal RAPD NP #frontal bone PS
60 Chandren 451619 34 M 18.8.09 LE RTA 1 2 PL + NI FH 2 RAPD pale disc NP NP N OS
61 Krishnamoorthy 451927 33 M 18.8.09 RE RTA 1 1 1/60. NI EB 2 RAPD Normal NP NP N PS
62 Kannan 452476 15 M 16.9.09 RE RTA 1 2 4/60. 6/36. FH 2 RAPD temporal pallor RAPD ALT #medial wall of optic canal OCD
63 Mohamadyasak 452506 17 M 17.9.09 LE Fall 1 1 HM+ NI FH 2 RAPD pale disc NP NP
#greater wing, # roof, floor, 
lat wall of orbit PS
64 Karthikeyan 452595 12 M 19.9.09 RE RTA 1 1 No PL NI OPS 2 RAPD Normal NP NP N PS
65 Krishnakumar 452624 29 M 8.10.09 RE RTA 1 1 6/60. NI FH 2 RAPD temporal pallor RAPD ALT #lateral wall of orbit PS
66 Vijayakumar 91967 26 M 29.10.09 LE RTA 1 2 HM+ NI FH 2 RAPD temporal pallor NP NP N OS
67 Babu 452970 21 M 6.11.09 RE RTA 1 1 PL + NI OPS 2 RAPD Normal NP NP N PS
68 Raja 92123 26 M 8.11.09 LE Fall 1 3 No PL NI FH 2 RAPD pale disc NP NP N OBS
69 swamikkannu 453143 52 M 10.11.09 RE RTA 1 1 1/60. NI FH 2 RAPD Normal RAPD N N PS
70 Ravi 453195 43 M 2.12.09 RE Fall 1 1 5/60. 6/24. SF 2 RAPD Normal RAPD ALT N PS
71 Rajaram 453221 18 M 14.12.09 LE assault 1 1 PL + NI FH 2 RAPD Normal NP NP N PS
72 Ashok 83467 29 M 23.12.09 RE RTA 1 2 PL + NI EB 2 RAPD temporal pallor NP NP #lat wall OS
73 Elango 83765 21 M 31.12.09 LE RTA 1 2 HM+ NI FH 2 RAPD temporal pallor NP NP #maxilla OS
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74 Sakthi 83965 20 M 1.1.10 LE RTA 1 2 6/60. 6/36. FH 2 RAPD Normal RAPD ALT N OS
75 Sankar 453334 33 M 4.1.10 LE Fall 1 1 PL + NI EB 2 RAPD Normal NP NP #roof PS
76 Veeraiyan 84387 47 M 14.1.10 RE RTA 1 4 No PL NI FH 2 RAPD pale disc NP NP #frontal bone OBS
77 Nirmal 84465 19 M 16.1.10 RE RTA 1 2 HM+ NI EB 2 RAPD temporal pallor NP NP #lat wall, #zygoma, #maxilla OS
78 Nagaraj 453387 24 M 26.1.10 LE RTA 1 1 2/60. 6/60. FH 2 RAPD Normal RAPD ALT N PS
79 Ulaganathan 453423 31 M 3.2.10 LE Fall 1 1 HM+ NI FH 2 RAPD Normal NP NP #frontal PS
80 Peter 84878 17 M 5.2.10 RE RTA 1 3 No PL NI EB 2 RAPD temporal pallor NP NP N OBS
81 Saradha 453496 28 F 16.2.10 RE RTA 1 1 6/24. 6/9. SF 2 RAPD Normal RAPD N N PS
82 Saied raj 453489 25 M 24.2.10 LE assault 1 1 1/60. 6/60. FH 2 RAPD Normal RAPD N N PS
83 David 453567 41 M 6.3.10 RE RTA 1 1 PL + NI FH 2 RAPD Normal NP NP #temporal bone PS
84 Govindhan 85321 36 M 7.3.10 LE RTA 1 3 PL + NI EB 2 RAPD pale disc NP NP #lat wall OBS
85 Kopinath 453589 27 M 15.3.10 RE RTA 1 1 HM+ 2/60. FH 2 RAPD Normal NP NP N PS
86 Ragavendren 85643 26 M 29.3.10 RE assault 1 2 2/60. NI EB 2 RAPD Normal RAPD EBS N OS
87 Mohan 453661 32 M 31.3.10 RE RTA 1 1 6/36P 6/9. FH 2 RAPD Normal RAPD N N PS
88 Prabu 453693 24 M 31.3.10 LE Fall 1 1 PL + No PL FH 2 RAPD Normal NP NP #maxilla, #lat wall PS
89 Ramu 453699 28 M 1.4.10 RE RTA 1 1 No PL NI EB 2 RAPD Normal NP NP #roof PS
90 Bakiaraj 453702 38 M 9.4.10 RE assault 1 1 PL + NI FH 2 RAPD Normal NP NP N PS
91 Cidambaram 86232 49 M 10.4.10 RE RTA 1 3 No PL NI EB 2 RAPD pale disc NP NP #zygoma OBS
92 Ravichandren 453787 30 M 16.4.10 LE Fall 1 1 HM+ No PL FH 2 RAPD Normal NP NP N PS
93 Thangamani 86456 21 M 16.4.10 RE RTA 1 3 No PL NI EB 2 RAPD pale disc NP NP #lat wall, #zygoma, #maxilla OBS
94 Prakash 453832 35 M 22.4.10 LE RTA 1 1 No PL NI FH 2 RAPD Normal NP NP N PS
95 Chellaiah 86675 29 M 28.4.10 RE RTA 1 2 HM+ NI FH 2 RAPD Normal NP NP N OS
96 Annamalai 453879 45 M 2.5.10 RE assault 1 1 No PL NI FH 2 RAPD Normal NP NP #temporal bone PS
97 Premkumar 86878 32 M 5.5.10 RE RTA 1 3 PL + NI EB 2 RAPD pale disc NP NP N OBS
98 Yokesh 453892 26 M 12.5.10 LE Fall 1 1 3/60. 6/36. SF 2 RAPD Normal RAPD N N PS
99 Saravanan 453956 35 M 17.5.10 LE RTA 1 1 HM+ 1/60. FH 2 RAPD temporal pallor NP NP N PS
100 Manikandan 86498 23 M 17.5.10 RE
g
wall 1 2 No PL NI EB 2 RAPD pale disc NP NP #lat wall haematoma OS
  
 
 
 
 
 
 
 
 
 
 
 
Intra ocular part of optic nerve 
 
 
                           
 
                           
 
 
 
 
 
 
 
Fundus picture of normal optic nerve head 
 
 
 
 
  
 
 
 
 
 
            
 
 
 
 
 
Blood supply of intraocular part and anterior portion of orbital 
part of optic nerve 
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Bony orbit showing the optic canal 
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Histology picture of perineural hematoma. 
 
  
                                       
                                   
 
 
Fundus picture showing optic nerve head avulsion 
                                                    
 
 
                                 
 
 
Fundus picture showing papilledema 
 
  
CT scan picture of orbit showing orbital hematoma compressing 
optic nerve 
 
 
CT scan picture showing optic nerve sheath hematoma. 
 
  
CT scan picture showing # floor and medial wall of orbit. 
 
CT scan picture showing optic nerve transection. 
                       
 
 
 
 
Fundus picture of papillitis 
 
 
 
 
  
Picture of patient no:58 showing scar over fore head 
 
Picture of pt.no:59 with injury over fore head and eyebrow. 
  
Field chart of pt.no:33 showing superior altitudinal defect. 
 
Field chart of pt.no:62 showing superior altitudinal defect. 
 
 
  
 
Fundus picture of patient no:65 showing temporal pallor RE 
 
 
 
Fundus picture of pt.no:68 showing pallor of the disc 
 
 
  
Fundus picture of pt.no:76 showing pallor of the disc 
 
Fundus picture of pt.no:81  showing normal fundus 
  
CT Scan picture of pt.no:62  showing # of medial  
wall of  Rt. Optic canal  
 
CT picture of the same pt. Showing # of lateral  
wall of Rt. orbit 
             
 
MRI scan of pt.no:58 showing edema optic nerve 
 
MRI scan of same pt. Edema optic nerve 
 
